Advancing Personalized Medicine: An Explainable AI-Driven Multi-Modal Organ-on-Chip Framework for Precision Drug Development

Structured Abstract Background: The traditional drug discovery pipeline is characterized by significant inefficiencies, including high costs, protracted timelines (13-15 years), and a low success rate, with less than 10% of drug candidates successfully reaching regulatory approval. A primary reason for this is the reliance on traditional preclinical models, such as animal testing, which often fail to accurately predict human responses, leading to high attrition rates in later clinical trial stages. Personalized medicine has emerged to address these challenges by tailoring therapies to an individual's unique characteristics. Methods: This paper proposes a novel AI-driven multi-modal data fusion framework that integrates diverse data from patient-specific Organ-on-a-Chip (OoC) systems, including real-time sensor data, high-content imaging, and 'omics data. The framework leverages advanced AI architectures, such as Transformer Networks and Graph Neural Networks, to analyse these data streams and enhance personalized drug efficacy and toxicity prediction. A crucial aspect of this framework is the integration of Explainable AI (XAI) techniques, such as SHAP and LIME, to provide transparent and interpretable insights into AI model decisions, addressing the "black box" problem and fostering clinical adoption. Results: The proposed framework is designed to overcome the limitations of traditional preclinical models by providing a more human-relevant, patient-specific platform for drug testing. The synergistic integration of AI and OoC is projected to accelerate drug development, substantially reduce costs, minimize ethical concerns associated with animal testing, and ultimately lead to the deployment of safer, more effective, and truly personalized therapies. Conclusion: This AI-driven multi-modal data fusion framework represents a necessary leap forward in drug development, offering a more efficient and ethical pathway toward realizing the full promise of personalized medicine. The emphasis on transparency and interpretability through XAI ensures that these technological advancements are deployed responsibly, building trust among healthcare professionals and patients alike.